4.4 Review

Enediyne anticancer antibiotic lidamycin: Chemistry, biology and pharmacology

Journal

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
Volume 8, Issue 2, Pages 123-131

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187152008783497055

Keywords

lidamycin; anticancer antibiotic; enediyne; DNA damage; cell cycle arrest; apoptosis; immunoconjugate; cancer therapy

Ask authors/readers for more resources

The enediyne antibiotics, the potent anticancer agents that contain diyne-ene functional groups, are appreciated for their novel molecular architecture, their remarkable biological activity and their fascinating mechanism of action. Their anticancer activity is apparently due to their ability to damage DNA through radical-mediated hydrogen abstraction. The enediyne antibiotics show markedly cytotoxicities against cancers in vitro and in vivo. Lidamycin is a member of the enediyne anticancer antibiotic family. This review examines lidamycin with particular emphasis on the discovery, the biological properties and its structure-activity relationships. In addition, the possible mechanisms of action of lidamycin are described. Recent progress, particularly in the areas of biosynthesis, and immunoconjugates are highlighted. Finally, the pharmacological applications of lidamycin in cancer therapy and its potential use as anticancer agents are also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available